RA-VII

• Description:

  RA-VII is an antitumor agent that exhibits significant activity against L1210, B-16 melanoma, Lewis lung carcinoma, Colon 38 and Ehrlich carcinoma[1].

• UNSPSC:

  12352209

• Target:

  Arp2/3 Complex

• Type:

  Peptides

• Related Pathways:

  Cytoskeleton

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/ra-vii.html

• Solubility:

  10 mM in DMSO

• Smiles:

  COC1=C2C=C (C[C@]3 ([H]) N (C ([C@] (N (C ([C@@H] (NC ([C@@H] (N (C ([C@@H] (NC ([C@H] (NC3=O) C) =O) C) =O) C) CC4=CC=C (C=C4) OC) =O) C) =O) C) ([H]) CC5=CC=C (O2) C=C5) =O) C) C=C1

• Molecular Formula:

  C41H50N6O9

• Molecular Weight:

  770.87

• References & Citations:

  [1]Itokawa H, et al. Isolation and antitumor activity of cyclic hexapeptides isolated from Rubiae radix. Chem Pharm Bull (Tokyo) . 1984 Jan;32 (1) :284-90.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported

• CAS Number:

  86229-97-2